TRAVERT 10% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travert 10% In Plastic Container, and when can generic versions of Travert 10% In Plastic Container launch?
Travert 10% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVERT 10% IN PLASTIC CONTAINER is invert sugar. Additional details are available on the invert sugar profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAVERT 10% IN PLASTIC CONTAINER?
- What are the global sales for TRAVERT 10% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TRAVERT 10% IN PLASTIC CONTAINER?
Summary for TRAVERT 10% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRAVERT 10% IN PLASTIC CONTAINER at DailyMed |
US Patents and Regulatory Information for TRAVERT 10% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVERT 10% IN PLASTIC CONTAINER | invert sugar | INJECTABLE;INJECTION | 016717-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
